Skip to main content

Market Overview

Barclays Upgrades Charles Schwab As The Fed Continues Its Trend To Normalization


Barclays on Thursday issued a report on Charles Schwab Corp (NYSE: SCHW), upgrading the brokerage service firm from Underweight to Overweight and raising the price target form $25 to $34.

Analyst Kenneth Hill wrote, "Overall, we see robust EPS growth from 2016 onward (averaging in the mid-20 percent range over the next three years)...Schwab remains the most levered name in our space to short-term rates, with an estimated $1.6 billion in incremental revenue expected after the first 100bps increase in the fed funds rate."

As rates continue to rise, Barclays believes that the firm can increase its revenues by bringing in additional assets to the balance sheet. Overall, Charles Schwab is best positioned to leverage its size to further enhance its position as an industry leader. As the federal government continues to move toward normalization, Charles Schwab should be in a great position for growth.

Charles Schwab closed Wednesday at $29.21.

Latest Ratings for SCHW

Apr 2021Credit SuisseUpgradesNeutralOutperform
Apr 2021Morgan StanleyMaintainsOverweight
Apr 2021CitigroupMaintainsBuy

View More Analyst Ratings for SCHW
View the Latest Analyst Ratings


Related Articles (SCHW)

View Comments and Join the Discussion!

Posted-In: Barclays Kenneth HillAnalyst Color Upgrades Price Target Analyst Ratings

Latest Ratings

FIBKStephens & Co.Downgrades
LEAFCanaccord GenuityDowngrades8.5
AGMSidoti & Co.Downgrades115.0
KEXGabelli & Co.Downgrades
OCGNCantor FitzgeraldDowngrades11.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at